Literature DB >> 14978252

Regulation of mouse renal CYP2J5 expression by sex hormones.

Jixiang Ma1, Joan Graves, J Alyce Bradbury, Yun Zhao, Deborah L Swope, Lorraine King, Wei Qu, James Clark, Page Myers, Vickie Walker, Jonathan Lindzey, Kenneth S Korach, Darryl C Zeldin.   

Abstract

Mouse CYP2J5 is abundant in kidney and active in the metabolism of arachidonic acid to epoxyeicosatrienoic acids. Western blots of microsomes prepared from mouse kidneys demonstrate that after puberty, CYP2J5 protein is present at higher levels in male mice than in female mice. Northern analysis reveals that CYP2J5 transcripts are more abundant in adult male versus female kidneys, indicating that gender differences in renal CYP2J5 expression are regulated at a pretranslational level. Castration of male mice results in decreased renal CYP2J5 expression, and treatment of castrated male mice or female mice with 5alpha-dihydrotestosterone increases expression to levels that approximate those in intact male mice. In contrast, treatment of ovariectomized female mice or castrated male mice with 17beta-estradiol causes a further reduction in CYP2J5 expression. Growth hormone-deficient (lit/lit) mice respond similarly to castration and 5alpha-dihydrotestosterone treatment, indicating that the androgen effects are not mediated by alterations in the growth hormone secretory pattern. Mice that lack a functional androgen receptor (Tfm hemizygous) have reduced levels of renal CYP2J5 and do not respond to 5alpha-dihydrotestosterone treatment. Similarly, wild-type male mice treated with flutamide, an androgen antagonist, exhibit reduced renal CYP2J5 levels. Female estrogen receptor-alpha knockout (alphaERKO) mice, which are known to have elevated circulating testosterone levels, have significantly increased renal CYP2J5 expression compared with wild-type female mice, and these differences are abrogated by ovariectomy or treatment with flutamide. Based on these data, we conclude that the renal expression of CYP2J5 is up-regulated by androgen and down-regulated by estrogen.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14978252     DOI: 10.1124/mol.65.3.730

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  11 in total

1.  Activity, inhibition, and induction of cytochrome P450 2J2 in adult human primary cardiomyocytes.

Authors:  Eric A Evangelista; Rüdiger Kaspera; Nahush A Mokadam; J P Jones; Rheem A Totah
Journal:  Drug Metab Dispos       Date:  2013-09-10       Impact factor: 3.922

Review 2.  Sex Differences in Human and Animal Toxicology.

Authors:  Michael Gochfeld
Journal:  Toxicol Pathol       Date:  2016-11-28       Impact factor: 1.902

3.  Gender differences in murine airway responsiveness and lipopolysaccharide-induced inflammation.

Authors:  Jeffrey W Card; Michelle A Carey; J Alyce Bradbury; Laura M DeGraff; Daniel L Morgan; Michael P Moorman; Gordon P Flake; Darryl C Zeldin
Journal:  J Immunol       Date:  2006-07-01       Impact factor: 5.422

4.  Transplacental exposure to inorganic arsenic at a hepatocarcinogenic dose induces fetal gene expression changes in mice indicative of aberrant estrogen signaling and disrupted steroid metabolism.

Authors:  Jie Liu; Yaxiong Xie; Ryan Cooper; Danica M K Ducharme; Raymond Tennant; Bhalchandra A Diwan; Michael P Waalkes
Journal:  Toxicol Appl Pharmacol       Date:  2007-02-06       Impact factor: 4.219

5.  Male sex hormones promote vagally mediated reflex airway responsiveness to cholinergic stimulation.

Authors:  Jeffrey W Card; James W Voltz; Catherine D Ferguson; Michelle A Carey; Laura M DeGraff; Shyamal D Peddada; Daniel L Morgan; Darryl C Zeldin
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2006-12-08       Impact factor: 5.464

6.  Androgen prevents hypogonadal bone loss via inhibition of resorption mediated by mature osteoblasts/osteocytes.

Authors:  Kristine M Wiren; Xiao-Wei Zhang; Dawn A Olson; Russell T Turner; Urszula T Iwaniec
Journal:  Bone       Date:  2012-08-14       Impact factor: 4.398

7.  Increased blood pressure in mice lacking cytochrome P450 2J5.

Authors:  Krairerk Athirakul; J Alyce Bradbury; Joan P Graves; Laura M DeGraff; Jixiang Ma; Yun Zhao; John F Couse; Raymond Quigley; David R Harder; Xueying Zhao; John D Imig; Theresa L Pedersen; John W Newman; Bruce D Hammock; Alan J Conley; Kenneth S Korach; Thomas M Coffman; Darryl C Zeldin
Journal:  FASEB J       Date:  2008-08-20       Impact factor: 5.191

Review 8.  Gender differences in kidney function.

Authors:  Ivan Sabolić; Abdul R Asif; Wolfgang E Budach; Christoph Wanke; Andrew Bahn; Gerhard Burckhardt
Journal:  Pflugers Arch       Date:  2007-07-19       Impact factor: 3.657

9.  Endothelial expression of human cytochrome P450 epoxygenases lowers blood pressure and attenuates hypertension-induced renal injury in mice.

Authors:  Craig R Lee; John D Imig; Matthew L Edin; Julie Foley; Laura M DeGraff; J Alyce Bradbury; Joan P Graves; Fred B Lih; James Clark; Page Myers; A Ligon Perrow; Adrienne N Lepp; M Alison Kannon; Oline K Ronnekleiv; Nabil J Alkayed; John R Falck; Kenneth B Tomer; Darryl C Zeldin
Journal:  FASEB J       Date:  2010-05-21       Impact factor: 5.191

10.  Pregnancy-Related Hormones Increase Nifedipine Metabolism in Human Hepatocytes by Inducing CYP3A4 Expression.

Authors:  Raju Khatri; Natasha Kulick; Rebecca J B Rementer; John K Fallon; Craig Sykes; Amanda P Schauer; Melina M Malinen; Merrie Mosedale; Paul B Watkins; Angela D M Kashuba; Kim A Boggess; Philip C Smith; Kim L R Brouwer; Craig R Lee
Journal:  J Pharm Sci       Date:  2020-09-12       Impact factor: 3.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.